To account for the effect of syndromic status on the levels of Abeta-42, p-tau, and total tau, we calculated the effect of mLRR-Y in two groups (MCI N = 148; dementia N = 66) and then performed an inverse-variance weighted fixed-effect meta-analysis. The gene discussed is MAPT; the disease is dementia.